LGG-12. SAFETY AND EFFICACY OF DUAL THERAPY WITH DABRAFENIB AND TRAMETINIB IN AN INFANT WITH BRAF V600E MUTANT INOPERABLE LOW GRADE GLIOMA

OBJECTIVE: To describe safety and efficacy of dual targeted therapy with dabrafenib (BRAFi) and trametinib (MEKi) in an infant with inoperable low grade glioma with BRAF V600E mutation. INTRODUCTION: Safety and efficacy of dual targeted therapy with BRAFi and MEKi for pediatric low grade glioma (pLG...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Sage, Walter, Andrew, Piatt, Joseph, Kaur, Gurcharanjeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Low Grade Gliomas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168189/
http://dx.doi.org/10.1093/neuonc/noab090.136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168189/
http://dx.doi.org/10.1093/neuonc/noab090.136

Ejemplares similares